CA2916125A1 - Imaging neurological disease - Google Patents
Imaging neurological disease Download PDFInfo
- Publication number
- CA2916125A1 CA2916125A1 CA2916125A CA2916125A CA2916125A1 CA 2916125 A1 CA2916125 A1 CA 2916125A1 CA 2916125 A CA2916125 A CA 2916125A CA 2916125 A CA2916125 A CA 2916125A CA 2916125 A1 CA2916125 A1 CA 2916125A1
- Authority
- CA
- Canada
- Prior art keywords
- imaging
- radiopharmaceutical
- normal
- ratio
- diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/501—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Neurosurgery (AREA)
- Dentistry (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nuclear Medicine (AREA)
- Pulmonology (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1313291.5A GB201313291D0 (en) | 2013-07-25 | 2013-07-25 | Imaging neurological disease |
| GB1313291.5 | 2013-07-25 | ||
| PCT/EP2014/066042 WO2015011267A1 (en) | 2013-07-25 | 2014-07-25 | Imaging neurological disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2916125A1 true CA2916125A1 (en) | 2015-01-29 |
Family
ID=49166921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2916125A Abandoned CA2916125A1 (en) | 2013-07-25 | 2014-07-25 | Imaging neurological disease |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11051777B2 (enExample) |
| EP (1) | EP3024501B1 (enExample) |
| JP (1) | JP6590801B2 (enExample) |
| KR (1) | KR102340504B1 (enExample) |
| CN (1) | CN105392500B (enExample) |
| AU (2) | AU2014294983B2 (enExample) |
| BR (1) | BR112016001316B1 (enExample) |
| CA (1) | CA2916125A1 (enExample) |
| DK (1) | DK3024501T3 (enExample) |
| ES (1) | ES2722973T3 (enExample) |
| GB (1) | GB201313291D0 (enExample) |
| IL (1) | IL243383B (enExample) |
| MX (1) | MX2016001012A (enExample) |
| RU (1) | RU2015155792A (enExample) |
| SG (1) | SG11201600571RA (enExample) |
| WO (1) | WO2015011267A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104720840A (zh) * | 2015-02-11 | 2015-06-24 | 清华大学深圳研究生院 | 基于多巴胺转运体显像特异性摄取比的半自动量化方法 |
| TWI587841B (zh) * | 2015-03-06 | 2017-06-21 | 國立陽明大學 | 定量分析核子醫學腦部影像的系統及方法 |
| US20180000440A1 (en) * | 2015-03-24 | 2018-01-04 | Nihon Medi-Physics Co., Ltd. | Image processing apparatus, image processing method, and program |
| KR101720288B1 (ko) | 2016-05-11 | 2017-03-28 | (주)바이오액츠 | 뇌 영상용 염료 및 이의 제조방법 |
| JP6549521B2 (ja) * | 2016-05-25 | 2019-07-24 | 富士フイルム富山化学株式会社 | 疾患鑑別支援装置及びコンピュータプログラム |
| TWI607739B (zh) * | 2016-05-27 | 2017-12-11 | 許百靈 | Ｓｐｅｃｔ多巴胺顯像定量分析技術與在腦多巴胺評估的用途 |
| GB201621698D0 (en) * | 2016-12-20 | 2017-02-01 | Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center | Differential Diagnosis |
| JP6995642B2 (ja) * | 2018-01-19 | 2022-01-14 | 日本メジフィジックス株式会社 | 画像処理装置、画像処理方法およびプログラム |
| TWI686178B (zh) * | 2019-10-09 | 2020-03-01 | 中原大學 | 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統 |
| US20230001026A1 (en) * | 2019-11-21 | 2023-01-05 | Likeminds, Inc. | Pharmaceutical packaging units and methods for concomitant administration of radiotracers |
| AR125188A1 (es) | 2021-03-22 | 2023-06-21 | Neurocrine Biosciences Inc | Inhibidores del vmat2 y métodos de uso |
| CN119599879B (zh) * | 2024-11-06 | 2025-10-24 | 复旦大学附属华山医院 | 一种基于深度学习的pet图像跨膜态合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009040727A2 (en) * | 2007-09-26 | 2009-04-02 | Philips Intellectual Property & Standards Gmbh | Method of differentially diagnosing different types of dementia |
| US8084018B2 (en) * | 2007-10-31 | 2011-12-27 | Alseres Pharmaceuticals, Inc. | Methods for imaging dopamine transporter level |
| US20100312105A1 (en) * | 2007-10-31 | 2010-12-09 | Alseres Pharmaceuticals, Inc. | Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
-
2013
- 2013-07-25 GB GBGB1313291.5A patent/GB201313291D0/en not_active Ceased
-
2014
- 2014-07-25 BR BR112016001316-6A patent/BR112016001316B1/pt active IP Right Grant
- 2014-07-25 CN CN201480041743.1A patent/CN105392500B/zh active Active
- 2014-07-25 WO PCT/EP2014/066042 patent/WO2015011267A1/en not_active Ceased
- 2014-07-25 DK DK14742544.1T patent/DK3024501T3/da active
- 2014-07-25 KR KR1020167001611A patent/KR102340504B1/ko active Active
- 2014-07-25 JP JP2016528546A patent/JP6590801B2/ja active Active
- 2014-07-25 RU RU2015155792A patent/RU2015155792A/ru unknown
- 2014-07-25 US US14/907,428 patent/US11051777B2/en active Active
- 2014-07-25 MX MX2016001012A patent/MX2016001012A/es unknown
- 2014-07-25 SG SG11201600571RA patent/SG11201600571RA/en unknown
- 2014-07-25 EP EP14742544.1A patent/EP3024501B1/en active Active
- 2014-07-25 CA CA2916125A patent/CA2916125A1/en not_active Abandoned
- 2014-07-25 AU AU2014294983A patent/AU2014294983B2/en active Active
- 2014-07-25 ES ES14742544T patent/ES2722973T3/es active Active
-
2015
- 2015-12-28 IL IL243383A patent/IL243383B/en active IP Right Grant
-
2019
- 2019-10-23 AU AU2019253837A patent/AU2019253837B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN105392500B (zh) | 2023-08-18 |
| WO2015011267A1 (en) | 2015-01-29 |
| IL243383B (en) | 2018-07-31 |
| RU2015155792A3 (enExample) | 2018-05-23 |
| US11051777B2 (en) | 2021-07-06 |
| GB201313291D0 (en) | 2013-09-11 |
| AU2014294983A1 (en) | 2016-01-21 |
| RU2015155792A (ru) | 2017-08-30 |
| JP6590801B2 (ja) | 2019-10-16 |
| HK1222118A1 (zh) | 2017-06-23 |
| ES2722973T3 (es) | 2019-08-20 |
| KR102340504B1 (ko) | 2021-12-20 |
| EP3024501A1 (en) | 2016-06-01 |
| KR20160037168A (ko) | 2016-04-05 |
| EP3024501B1 (en) | 2019-03-27 |
| DK3024501T3 (da) | 2019-05-06 |
| BR112016001316B1 (pt) | 2021-04-06 |
| US20160183897A1 (en) | 2016-06-30 |
| SG11201600571RA (en) | 2016-02-26 |
| JP2016531903A (ja) | 2016-10-13 |
| AU2014294983B2 (en) | 2019-10-24 |
| AU2019253837A1 (en) | 2019-11-14 |
| AU2019253837B2 (en) | 2021-11-25 |
| CN105392500A (zh) | 2016-03-09 |
| MX2016001012A (es) | 2016-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019253837B2 (en) | Imaging neurological disease | |
| Politis et al. | Positron emission tomography imaging in neurological disorders | |
| Zhu et al. | PET/SPECT imaging agents for neurodegenerative diseases | |
| Villemagne et al. | In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease | |
| Ferreira et al. | Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications | |
| Nocker et al. | Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I] β-CIT SPECT | |
| Masterman et al. | Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias | |
| Schreckenberger et al. | The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism | |
| Henderson | The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging | |
| Hsiao et al. | Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson’s disease patients | |
| JP2011502966A5 (enExample) | ||
| JP2014148529A (ja) | ドーパミン輸送体レベルを造影するための方法 | |
| Booij et al. | Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible | |
| Perlmutter | New insights into the pathophysiology of Parkinson's disease: the challenge of positron emission tomography | |
| Varrone et al. | Molecular imaging of neuroinflammation in Alzheimer’s disease | |
| Edison et al. | Strategies for the generation of parametric images of [11C] PIB with plasma input functions considering discriminations and reproducibility | |
| Caroli et al. | Quantitative evaluation of Alzheimer’s disease | |
| Hawkins | Pancreatic tumors: imaging with PET. | |
| HK1222118B (zh) | 成像神经学疾病 | |
| Leonardo et al. | The emerging role of PET imaging in dementia | |
| Niethammer et al. | PET and SPECT Imaging in Atypical Parkinsonian Syndromes | |
| Ducksbury et al. | SPECT/PET findings in Lewy body dementia | |
| Lew | Evaluating SPECT/CT quantification in clinical practice | |
| Fernandez et al. | [123I]-Altropane SPECT: How It Compares to Other Positron Emission Tomography and Single-Photon Emission Tomography Dopamine Transporters in Early Parkinson’s Disease | |
| Scherfler et al. | Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I] β-CIT SPECT analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190724 |
|
| FZDE | Discontinued |
Effective date: 20220316 |
|
| FZDE | Discontinued |
Effective date: 20220316 |